# Octaplas Pediatric Plasma Exchange Trial

> **NCT01938378** · PHASE4 · COMPLETED · sponsor: **Octapharma** · enrollment: 41 (actual)

## Conditions studied

- Adverse Effects in the Therapeutic Use of Plasma Substitutes

## Interventions

- **BIOLOGICAL:** Octaplas™

## Key facts

- **NCT ID:** NCT01938378
- **Lead sponsor:** Octapharma
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2015-04
- **Primary completion:** 2019-01-27
- **Final completion:** 2019-01-27
- **Target enrollment:** 41 (ACTUAL)
- **Last updated:** 2020-03-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01938378

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01938378, "Octaplas Pediatric Plasma Exchange Trial". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT01938378. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*